Skip to main content
. 2024 Jan 22;14:1265469. doi: 10.3389/fimmu.2023.1265469

Figure 7.

Figure 7

Representative examples of HLA class I immunostaining in advanced pediatric solid tumors. All tumor cells in a case of Ewing sarcoma (A) and a case of ependymoma (B) are homogeneously and strongly labeled by anti-HLA class I antibody (V, tumor vessel). In (C) all tumor cells in this other case of Ewing sarcoma are reactive with anti-HLA class I antibody but with variable apparent levels of intensity (V, tumor vessel as internal control). In a case of HGG (D) and in a case of osteosarcoma (E), HLA class I shows a patchy expression in tumor cells (V, tumor vessel; arrowheads, immune cells). In this case of nephroblastoma (F), HLA class I is strongly expressed by mesenchymal cells (M) and tubular epithelial structures (arrowheads) but is undetectable in undifferentiated blastema cells. In a case of neuroblastoma (G) and a case of rhabdomyosarcoma (H), HLA class I is undetectable on tumor cells while immune cells (arrowheads) and tumor vessels (V) are labeled. Indirect immunoperoxidase with nuclear counterstaining by hematoxylin. Original magnifications: (A–C) x220; (D) x280; (E) x220; (F) x180; (G) x320; (H) x280.